Get started
Author

Archita Sarmah

Observed names: A Sarmah, Sarmah, Archita
ORCID: 0000-0003-3857-3894
Observed ORCID: 0000-0003-3857-3894
OpenAlex ID: A5042409230
Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients
2022 · Francesco Saverio Mennini, Francesco Meucci, et al. · International Journal of Cardiology · 27
PDF
Compulsory licenses in the pharmaceutical industry: Pricing and R&D strategies
2019 · Archita Sarmah, Domenico De Giovanni, et al. · European Journal of Operational Research · 22
PDF
Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk
2023 · Karl H. Kuck, Reiner Leidl, et al. · Advances in Therapy · 19
PDF
Cost-effectiveness of SAPIEN 3 transcatheter aortic valve implantation in low surgical mortality risk patients in Spain
2022 · José Manuel Vázquez Rodríguez, Eduardo Pinar Bermúdez, et al. · REC interventional cardiology (English Edition) · 8
A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation for Symptomatic Severe Aortic Stenosis
2023 · Laura Heathcote, Tushar Srivastava, et al. · ClinicoEconomics and Outcomes Research · 5
PDF
Cost-effectiveness analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at low risk of surgical mortality in Sweden
2024 · Konrad Nilsson, Stefan James, et al. · Upsala Journal of Medical Sciences · 4
Coste-efectividad del implante percut�neo de v�lvula a�rtica con SAPIEN 3 en pacientes con bajo riesgo de mortalidad quir�rgica en Espa�a
2022 · José Manuel Vázquez Rodríguez, Eduardo Pinar Bermúdez, et al. · REC, Interventional cardiology · 1
Allying with a prospective rival: New entrant-incumbent R&D alliance formation.
2017 · Archita Sarmah, Ha Hoang · Academy of Management Proceedings · 1
EPH5 The Burden of Severe Symptomatic Aortic Stenosis in Spain: Can Capacity-Enhancing Innovations Play a Role in Addressing the Growing Demand for Treatment?
2024 · EP Bermúdez, JM de la Torre Hernández, et al. · Value in Health
EE533 Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Low Surgical Risk Symptomatic Severe Aortic Stenosis Patients in Brazil
2024 · A Sarmah, CA Polanczyk, et al. · Value in Health
PDF
EE365 Economic Evaluation of Transcatheter Aortic Valve Implantation (TAVI) Relative to Other Interventions in Cardiovascular and Oncology Disease Areas: A Targeted Literature Review
2024 · A Sarmah, P Candolfi, et al. · Value in Health
PDF
EE185 Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Low Surgical Risk Patients With Severe Symptomatic Aortic Stenosis in Germany
2022 · L Frankenstein, R Leidl, et al. · Value in Health
PDF
HTA20 A Systematic Review and Statistical Analysis of Factors Influencing the Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) for Severe Symptomatic Aortic Stenosis
2022 · L Heathcote, P Candolfi, et al. · Value in Health
POSA54 Cost-Effectiveness of Transcatherer Aortic Valve Implantation (TAVI) in Low Surgical Risk Patients with Severe Aortic Stenosis in Spain
2022 · M Green, A Sarmah, et al. · Value in Health
PDF
Permanent Exit or Temporary Break? Organizational Experience and Market Reentry after Initial Exit
2018 · Archita Sarmah · Academy of Management Proceedings
Three essays in the biopharmaceutical industry building on a process perspective of market entry
2018 · Archita Sarmah · theses.fr (ABES)
PDF
Works count: 17
Citation count: 87
H-index: 5
I10-index: 3
Year
Topic
Type